Navigation Links
Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
Date:9/26/2007

LONDON and NEW YORK, Sept. 26 /PRNewswire/ -- The Financial Times has selected the Campaign for Female Education (CAMFED) for the second year running for its seasonal charity appeal to readers. CAMFED supports girls' education in rural communities in Africa.

Last year's appeal raised more over 600,000 pounds Sterling ($1.2 million) for CAMFED. The Financial Times will run a series of articles from November through to mid-January highlighting CAMFED's work. The articles will feature the accomplishments of young women who have been supported through their education by the organisation's programmes. Financial Times journalists will also report from Africa on how the money raised in the 2006 appeal was spent. It is hoped this special series will encourage readers to donate to the organisation and greatly increase awareness of the importance of girls' education worldwide.

Announcing the partnership with the Financial Times at the Clinton Global Initiative in New York, Ann Cotton, Executive Director of CAMFED said, "It is widely recognised that girls' education is the best vaccine we have against HIV/AIDS. Educated women, quite simply, transform the economic and social fabric of their communities. Building on the success of last year's campaign, CAMFED is honoured to partner with the Financial Times again."

Founded in 1993 when CAMFED awarded scholarships to the first 32 girls, the charity has since grown to support over 300,000 children and young people in Zimbabwe, Zambia, Ghana and Tanzania. CAMFED's programme supports girls through childhood and adolescence to young adulthood, meeting all educational costs, including school clothing, fees and stationery and then providing micro finance with training to support entrepreneurship. CAMFED makes a minimum five year financial commitment to each girl.

Lionel Barber, editor of the Financial Times, said: "We are delighted that we are able to work for a second year with CAMFED International, after
'/>"/>

SOURCE The Financial Times
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Financial Allowances Being Offered To Poor Vietnamese HIV Carriers
2. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
3. Health conditions and patient treatment affected by a financial crunch
4. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
5. Bird Flu: Fear of the Unknown Could Put Financial Markets in a Soup
6. Huge financial losses due to Bird flu scare!
7. Sexual Health Service Is Under Pressure and Faced With Financial Challenges
8. Elective Surgery - the Financial Whipping Boy
9. British Hospitals Face Financial Crisis
10. Kidney donors do not realize financial gains
11. Bird-Flu Pandemic will be a Huge Financial Drain, says World Bank

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Nov. 9 At a time when the 250,000+...ingly concerned about finding affordable health in...on for 2010. ,, The Today,s Options® Prefe...e plan provides a cost-effective and comprehensive...pplement plan. People with Medicare can choose to...
(Date:11/9/2009)... The American Academy of...an 75,000 clinically practicing physician assistan... the U.S. House of Representatives for passing Sat...Affordable Health Care for America Act. ,, "We ...l ultimately lower the cost of health care and gre...
(Date:11/9/2009)...earch Hospital and the University of Florida Proto... provide proton therapy for St. Jude patients. The...inical study to evaluate the use of proton therapy... years old. , Under the clinical protocol, St....y at the UF Proton Therapy Institute in Jacksonvil...
(Date:11/9/2009)...9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ...announced the availability of INTUNIV (guanfacine)... United States for the treatment of Attention-Defi...adolescents ages 6 to 17. INTUNIV, a once-daily f...nscheduled alpha-2A receptor agonist approved for ...
(Date:11/9/2009)... 2009 The first human embryonic stem cell treatme...shown to restore limb function in rats with neck s...he clinical trial to include people with cervical ...istration gave Geron Corp. of Menlo Park, Calif., ...viduals with thoracic spinal cord injuries, which ...
Breaking Medicine News(10 mins):Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2
... China, Nov. 7 /Xinhua-PRNewswire-FirstCall/ -- Ch...lletin Board: CPHI), which,develops, manufactures,...ceutical products in China, today announced financ...lion Revenue for nine months ended September 30, u...
... health plans evaluated based on quality of care, ...oup and The,National Committee for Quality Assuran... of America,s Best Health Plans on USNews.com. Lau... provides,comprehensive rankings and important con...
...Fraxel laser treatment highlighted in several podi...gic Surgery,s Annual Meeting, ORLANDO, Fla., Nov....ctional resurfacing and market leader of aesthetic...ed at the,American Society for Dermatologic Surger...
...e brand with mangosteen BioActiveX3 Complex(TM) fe...chnology in self-adjusting ...nutrition leader XanGo,LLC, today announced the of...ingredients from the mangosteen delivered through,...
.... 7 NutraCea (OTC Bulletin Board:,NTRZ), a world ...arch and,technology, today announced financial res...8., Net revenues for the 2008 third quarter incre...venues from the,Company,s NutraCea segment and $7....
..., Mich., Nov. 7 The,patient-centered medical home... coverage will be among the topics at the annual "...igan State Medical Society (MSMS),on Tuesday, Nov....of the emerging health care model that ensures coo...
Other Medicine News:Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 2Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 3Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 4Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 5Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 6Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 7Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 8Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 9Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 10Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 2Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 3Health News:Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to 'Pseudo Fractional' Laser Technologies 2Health News:Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to 'Pseudo Fractional' Laser Technologies 3Health News:Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to 'Pseudo Fractional' Laser Technologies 4Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 2Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 3Health News:NutraCea Announces Third Quarter 2008 Financial Results 2Health News:NutraCea Announces Third Quarter 2008 Financial Results 3Health News:NutraCea Announces Third Quarter 2008 Financial Results 4Health News:NutraCea Announces Third Quarter 2008 Financial Results 5Health News:NutraCea Announces Third Quarter 2008 Financial Results 6Health News:NutraCea Announces Third Quarter 2008 Financial Results 7Health News:NutraCea Announces Third Quarter 2008 Financial Results 8Health News:NutraCea Announces Third Quarter 2008 Financial Results 9
(Date:11/9/2009)...ov. 9 PAREXEL Internatio... biopharmaceutical services provider, today announ...lities for early phase clinical development throug... manufactures and distributes electrocardiogram (E...XEL is using Mortara Instrument,s Surveyor Telemet...
(Date:11/7/2009)...CH, Fla., Nov. 7 Most patients wit...oms that signal an oncoming HAE attack giving the ... decrease the morbidity associated with that attac... the 2009 American College of Allergy, Asthma &...tion of symptoms such as fatigue and nausea, which...
(Date:11/6/2009)...N, Mass., Nov. 6 DUSA Ph...ermatology company that is developing and marketin...ther products focused on patients with common skin...nd Chief Executive Officer, will present a corpora...ummit 2009 on Tuesday, November 10, 2009 at 10:00 ...
Breaking Medicine Technology:PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 1BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 2Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 1Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 2Blood Transfusions Not Linked to Long Term Problems 53386 1
...s Overall Psychological Toll Is Greater Than for A...Pa., May 17, 2007 /PRNewswire/ -- Nearly three out...cent) responding to a,new nationwide survey say no...urthermore, they describe UC as disruptive when it...cent), their sexual,relations (75 percent) and the...
...USALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx ...nt company, announced today,that abstracts contain...linical trails of BL-1020, first in class GABA-enh...enia, have been,accepted for poster presentations ...will be presented at the following,conferences:, -...
Other Medicine Technology:Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3
CA-125 Enzyme Immunoassay Test Kit
Immulite PAP
Mosaic
...s a neurosurgical OR that fully integrates all the...cessary to treat complicated neurosurgical cases. ... performed in a workflow optimized manner. Pre-tes...BrainSUITE iMRI guarantees rapid implementation in...
Medicine Products: